ANEMIA HEMOLITICA AUTOINMUNE PDF

La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.

Author: Shakagis Tojataur
Country: Singapore
Language: English (Spanish)
Genre: Politics
Published (Last): 16 April 2004
Pages: 36
PDF File Size: 13.49 Mb
ePub File Size: 2.10 Mb
ISBN: 255-9-98366-671-9
Downloads: 28273
Price: Free* [*Free Regsitration Required]
Uploader: Gardalabar

Lupus, 24pp. The James Blundell Award Lecture A variety of other immunosuppressive agents as well as splenectomy are used for refractory cases.

Published studies are primarily clinical and epidemiological research but also basic. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon- a. Ann Hematol, 89pp.

Anemia Hemolítica Autoinmune

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia. The anti-CD20 monoclonal antibody rituximab has gained widespread acceptance in the management of haematologic disorders with autoantibodies production. American Red Cross; CiteScore measures average citations received per document published.

It was detected the presence of IgG and C3 in American Association of Blood Banks; Br J Clin Pharmacol, 79pp. Estos resultados son similares a los obtenidos en los pacientes con AHAI y en la anemia autoinmune secundaria al tratamiento con alfa metildopa. To improve our services and products, we use “cookies” own or yemolitica parties authorized to hemmolitica advertising related to client preferences through the analyses of navigation customer behavior.

  APPUNTI DI MECCANICA RAZIONALE DE RIENZO PDF

Hemolytic anemia secondary to interferon treatment for chronic B hepatitis. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: Autoinmune hemolytic anemia during interferon treatment in nine patients with hematological diseases.

Hemoliticx role of rituximab auttoinmune adults with warm antibody autoimmune hemolytic anaemia. Rituximab in the treatment of autoimmune haemolytic anaemia. Rev Cub Hematol Inmunol Hemoter. Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and hemolktica patients who are medically unsuited for espenectomy.

They underwent tests for immune protein detection and characterization of IgG subclasses in RBCs by direct antiglobulin test PAD and the microplate technique. First-line treatment for chronic myeloid leukemia: Si continua navegando, consideramos que acepta su uso.

Bienvenido a siicsalud Contacto Inquietudes. Interferon in oncology practice: Subscribe to our Newsletter. Key words autoimmune haemolytic anaemia, cold agglutinin disease, rituximab. Br J Haematol,pp. Previous article Next article.

Anemia Hemolítica Autoinmune | Medical City McKinney

Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge. Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. Do we really understand immune red cell destruction? You can change the settings or obtain more information by clicking here.

  HAZEN WILLIAMS NOMOGRAPH PDF

Immune-mediated complications during interferon therapy in hematological patients. Read this article in English. Quantitation of red cell-bound IgG, IgA, and IgM in patients with autoimmune hemolytic anemia and blood donors by enzyme-linked immunosorbent assay.

Rituximab in the treatment of autoinmune haematological disorders. Baier JE, Poehlau D. Rev Cubana Hematol Inmunol Hemoter, 29pp. Petz LD, Garraty G.

DESTACAN LA UTILIDAD DEL RITUXIMAB PARA TRATAR LA ANEMIA HEMOLITICA AUTOIMMUNE

Therefore, properly designed clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted. En todos los pacientes, el tratamiento con IFN a fue suspendido al demostrarse la presencia de autoanticuerpos eritrocitarios. Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus. July – August Pages Is a -methyldopa-type autoimmune hemolytic anemia mediated by interferon- g? La PAD y la Mp fueron negativas en un caso.

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Haemolytic anemia to the alpha anwmia treatment: Rituximab therapy has a rapid and durable response for refractory cytopenia auyoinmune childhood-onset systemic lupus erythematosus.